---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-022978"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:12:16.190426+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nephros Q2 net rev $4.4M (+36% YoY); net income $237k vs loss $289k; 3rd consecutive profitable quarter

## Summary
- Net revenue $4.4M, up 36% YoY from $3.3M; net income $237k vs net loss $289k.
- Adjusted EBITDA $355k vs $(133k); gross margin improved to 63% from 59%.
- Six-month net income $795k vs loss $458k; revenue $9.3M (+37% YoY).
- Programmatic sales all-time high; largest dialysis filtration PO in company history.
- Cash $5.1M, debt-free; active-site counts at all-time highs.

## SEC filing metadata
- accession: 0001641172-25-022978
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000164117225022978/0001641172-25-022978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000164117225022978/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-022978
- JSON: https://secwatch.observer/filing/0001641172-25-022978.json
- Plain text: https://secwatch.observer/filing/0001641172-25-022978.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.